日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SF3B1 mutation accelerates the development of CLL via activation of the mTOR pathway

SF3B1突变通过激活mTOR通路加速慢性淋巴细胞白血病(CLL)的进展。

Bo Zhang ,Prajish Iyer ,Meiling Jin ,Elisa Ten Hacken ,Zachary J Cartun ,Kevyn L Hart ,Mike Fernandez ,Kristen Stevenson ,Laura Rassenti ,Emanuela M Ghia ,Thomas J Kipps ,Donna Neuberg ,Ruben Carrasco ,Wing C Chan ,Joo Y Song ,Yu Hu ,Catherine J Wu ,Lili Wang

SF3B1 mutation and ATM deletion codrive leukemogenesis via centromeric R-loop dysregulation

SF3B1 突变和 ATM 缺失通过着丝粒 R 环失调共同驱动白血病形成

Martina Cusan, Haifeng Shen, Bo Zhang, Aijun Liao, Lu Yang, Meiling Jin, Mike Fernandez, Prajish Iyer, Yiming Wu, Kevyn Hart, Catherine Gutierrez, Sara Nik, Shondra M Pruett-Miller, Jeremy Stark, Esther A Obeng, Teresa V Bowman, Catherine J Wu, Ren-Jang Lin, Lili Wang

METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL

METTL3介导的m6A修饰控制剪接因子丰度并促进侵袭性慢性淋巴细胞白血病(CLL)的发生。

Yiming Wu #,Meiling Jin #,Mike Fernandez,Kevyn L Hart,Aijun Liao,Xinzhou Ge,Stacey M Fernandes,Tinisha McDonald,Zhenhua Chen,Daniel Röth,Lucy Y Ghoda,Guido Marcucci,Markus Kalkum,Raju K Pillai,Alexey V Danilov,Jingyi Jessica Li,Jianjun Chen,Jennifer R Brown,Steven T Rosen,Tanya Siddiqi,Lili Wang